Medicamen Organics Limited IPO
NSE SMEListed On: Jun 28, 2024 at ₹ 137.85
₹ 272000 /8000 Shares
*Min Investment
21 Jun, 2024
Open Date25 Jun, 2024
Close Date26 Jun, 2024
Allotment Date28 Jun, 2024
Listing DateMedicamen Organics Limited IPO Issue Details
- Issue Price ₹32-34 per equity share
- Face Value ₹10 Per Equity Share
- Total Issue Size 31,00,000 shares(aggregating up to ₹10.54 crore)
- Fresh Share 31,00,000 shares(aggregating up to ₹10.54 crore)
- Listing at NSE SME
- List Price 137.85
- Listing Date 2024-06-28
- Lead Manager GYR Capital Advisors Private Limited
- Registrar Kfin Technologies Limited
Market Lot Size
Investors can bid for a minimum of 4000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 4000 | ₹1,36,000 |
| Retail(max) | 1 | 4000 | ₹1,36,000 |
| NII (min) | 2 | 8,000 | ₹2,72,000 |
Medicamen Organics Limited IPO Reservation
Medicamen Organics Limited IPO offers total 3,100,000 shares. Out of which 584,000 (18.84%) allocated to QIB, 440,000 (14.19%) allocated to NII,1,028,000 (33.16%) allocated to RII, NA (NA%) allocated to employees and 876,000 (28.26%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 876,000 (28.26%) | |
| Market Maker Shares Offered | 172,000 (5.55%) | |
| QIB Shares Offered | 584,000 (18.84%) | |
| NII (HNI) Shares Offered | 440,000 (14.19%) | |
| Retail Shares Offered | 1,028,000 (33.16%) | |
| Total Shares Offered | 3,100,000 (100%) |
Medicamen Organics Limited IPO Details
Medicamen Organics Limited IPO is an SME IPO, priced at ₹32-34 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform. The IPO comprises a total issue of 31,00,000 equity shares, aggregating up to ₹10.54 crores..
The IPO bidding window is open from Jun 21, 2024 to Jun 25, 2024. The allotment is expected to be finalized on Jun 26, 2024, and the tentative listing date is Jun 28, 2024.
The minimum lot size for Retail investors is 4000 shares, with a minimum investment of ₹1,36,000. For HNIs, the minimum application size is 2 lots , amounting to ₹ 2,72,000.
GYR Capital Advisors Private Limited is acting as the lead manager to the issue. The registrar of the IPO is Kfin Technologies Limited, and Giriraj Stock Broking Private Limited will act as the market maker for this issue.
Medicamen Organics Limited IPO Subscription Analysis And Details
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 584,000 / 440,000 | 1,028,000 | 2,052,000 |
Day 1 21-06-24 06:00 PM | 1.01 / 37.20 x | 92.26 x | 54.49 x |
Day 2 24-06-24 06:00 PM | 1.42 / 125.83 x | 348.14 x | 201.79 x |
Day 3 25-06-24 06:00 PM | 173.03 / 1344.22 x | 1309.77 x | 993.64 x |
Medicamen Organics Limited Valuations
Medicamen Organics Limited Company Financials
| 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|
| Assets | 3,858.07 | 3,211.98 | 2,707.21 |
| Revenue | 2,528.96 | 2,296.24 | 2,118.67 |
| Profit After Tax | 240.41 | 95.78 | 9.23 |
| Net Worth | 1,518.40 | 851.71 | 755.92 |
| Reserves & Surplus | 658.40 | 251.71 | 155.92 |
| Total Borrowing | 1,265.65 | 1,179.50 | 1,024.57 |
About Medicamen Organics Limited Company
Medicamen Organics Limited was established in 1995 and engages in the development, manufacture, and marketing of pharmaceutical dosages, including generic dosages, in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders to the Government (State Governments and Central Governments) and private parties as a contract manufacturer/third-party manufacturer.
The company's product list includes 84 products and a wide range of drugs such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral and non-steroidal anti-inflammatory drugs (NSAIDS).
The company sells its products all over India as well as in African, CIS, and South East Asian countries such as Congo, Benin, Kameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya through third-party distributors.
There are two WHO-GMP compliant manufacturing plants covering 21,536 Sq. Ft of Haridwar in Uttarakhand. By the date September 30, 2023, it entered a contract with manufacturing deals at domestic end through 38 companies and had the number of Merchant exporters totaling at 12 entities.
As of September 30, 2023, the total number of people employed by the company is 116.
Medicamen Organics Limited - Promoter(s)
Mr. Bal Kishan Gupta
Pre Issue Share Holding : 81.21%
Post Issue Share Holding : %
Medicamen Organics Limited IPO - Issue Objectives
Funding of expenses proposed to be incurred towards Product registration in the international markets
Plant updation and increase in production capacity
Funding working capital requirements of our Company
General Corporate Purposes.
Medicamen Organics Limited IPO - Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Medicamen Organics Limited | 3.18 | 3.18 | 17.66 | N/A | 15.83 | 1.93 | Restated Financial Statement |
| Brooks Laboratories Ltd. | -12.57 | -12.57 | 30.1 | 10.6 | -28.26 | 4.43 | Standalone Financial Statement |
| Cian Healthcare Ltd | 0.43 | 0.43 | 22.4 | 53.84 | 1.75 | 1.03 | Standalone Financial Statement |
| Zenotech Laboratories Ltd. | 1.9 | 1.9 | 14.2 | 38.76 | 14.08 | 5.19 | Standalone Financial Statement |
Notes:
- NAV per share is computed as the closing net worth divided by the weighted average number of paid-up equity shares as on March 31, 2024.
- RoNW has been computed as net profit after tax divided by closing net worth.
- Net worth has been computed in the manner as specified in Regulation 2(1)(hh) of SEBI (ICDR) Regulations, 2018.
Contact Details
Medicamen Organics Limited
10 Community Centre,, No 2 Ashok Vihar Phase II, New Delhi, Delhi, 110052
+91-9818222845
Registrar Contact Details
Kfin Technologies Limited
04067162222, 04079611000
Medicamen Organics Limited IPO - FAQs
Ans. Medicamen Organics Limited IPO is a SME IPO. The issue is priced at ₹32-34 per equity share. The minimum order quantity is 4000 Shares. The IPO opens on Jun 21, 2024, and closes on Jun 25, 2024. Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Ans. The Medicamen Organics Limited IPO opens on Jun 21, 2024 and closes on Jun 25, 2024.
Ans. You can track the real-time subscription numbers using the links below:
Ans. The size of Medicamen Organics Limited IPO is 3,100,000 shares(aggregating up to ₹10.54 Cr).
Ans. The Medicamen Organics Limited IPO price band is set between ₹32-34 per equity share.
Ans. To apply for Medicamen Organics Limited IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Medicamen Organics Limited IPO in the List of IPOs
- - Press Apply Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Medicamen Organics Limited IPO is Jun 26, 2024.
Ans. The Medicamen Organics Limited IPO will be listed on Jun 28, 2024.
Ans. Follow the steps to check the Medicamen Organics Limited IPO allotment status online.
